Plain-English explainers for the science terms in mushroom & psychedelic research.
Key Takeaways ›Nerve growth factor (NGF) supports neuron health and repair, playing a key role in brain plasticity linked to psychedelic therapy effects. ›Research explores how psychedelics like psilocybin may influence NGF levels, potentially enhancing neuroplasticity and mental health outcomes. ›NGF is an endogenous protein, not a supplement, and its role in therapy remains associated…
Key Takeaways ›Lion’s Mane mushroom may support brain health by stimulating nerve growth factor production, though it does not prove direct cognitive enhancement. ›Its bioactive compounds can cross the blood–brain barrier, suggesting potential neuroprotective effects, but evidence remains largely preliminary and observational. ›Lion’s Mane is not psychoactive and is sometimes used in microdose protocols with…
Key Takeaways ›The 5-HT2A receptor is a key brain target for psychedelics, linked to altered perception and cognition, but does not prove it causes all mental health effects. ›Research on this receptor helps map how psychedelics influence brain networks and may guide the development of new treatments for depression and addiction. ›While the 5-HT2A receptor…
Key Takeaways ›Psychedelics like psilocybin may temporarily disrupt the default mode network, potentially leading to shifts in self-perception and emotional processing. ›The default mode network is a dynamic system involved in self-referential thought, not a fixed ‘brain setting’ that can be simply turned on or off. ›Research on DMN dynamics suggests psychedelics may enhance neural…
Key Takeaways ›Psychedelics like psilocybin may temporarily enhance neuroplasticity, potentially aiding the brain in forming new neural pathways linked to mental health recovery. ›Neuroplasticity is a continuous, gradual process that occurs throughout life, not just a sudden reset as commonly misunderstood. ›While research suggests psychedelics could help rewire maladaptive circuits, it does not prove they…